Chronic Liver Disease
Chronic liver disease refers to the progressive deterioration of liver function caused by ongoing injury to liver tissue. Over time, this damage leads to inflammation, fibrosis (scar tissue formation), and eventually cirrhosis—an advanced stage marked by severe structural disruption and impaired blood flow through the liver.
The liver is a critical organ responsible for over 500 vital functions, including detoxifying harmful substances, producing clotting factors and immune proteins, metabolizing nutrients and medications, regulating blood sugar, storing vitamins and minerals, producing bile for digestion, and synthesizing cholesterol and lipids. As liver function declines, widespread systemic effects can occur.
Chronic liver disease affects millions globally and is a leading cause of morbidity and mortality. Cirrhosis ranks among the top causes of death worldwide. Because symptoms often appear late, it is frequently referred to as a “silent disease.”
Disease Progression
Chronic liver disease typically advances through several stages:
-
Inflammation: Early liver cell injury with minimal functional impairment
-
Fibrosis: Accumulation of scar tissue replacing healthy liver cells
-
Cirrhosis: Extensive scarring disrupting liver structure and blood flow
-
End-stage liver disease: Severe dysfunction or liver failure
Common Causes
-
Chronic viral hepatitis (B and C): Persistent infection leading to long-term inflammation
-
Non-alcoholic fatty liver disease (NAFLD): Fat accumulation in the liver, often linked to obesity, diabetes, and metabolic syndrome
-
Alcohol-related liver disease: Long-term excessive alcohol intake
-
Autoimmune liver diseases: Including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis
-
Genetic conditions: Such as hemochromatosis (iron overload), Wilson disease (copper accumulation), and alpha-1 antitrypsin deficiency
-
Medication-related injury: From drugs like methotrexate, amiodarone, or certain supplements
Symptoms
Symptoms vary by stage and severity:
Early-stage:
-
Fatigue
-
Loss of appetite
-
Mild abdominal discomfort
-
General malaise
Advanced disease:
-
Jaundice (yellowing of skin and eyes)
-
Dark urine, pale stools
-
Itching (pruritus)
-
Easy bruising or bleeding
-
Swelling in legs (edema)
-
Abdominal fluid buildup (ascites)
-
Spider angiomas
-
Palmar erythema
-
Confusion (hepatic encephalopathy)
-
Enlarged spleen (splenomegaly)
Diagnosis
Evaluation typically includes:
-
Blood tests:
-
Liver enzymes (ALT, AST, ALP)
-
Bilirubin
-
Albumin and prothrombin time
-
Complete blood count
-
-
Cause-specific testing:
-
Viral hepatitis panels
-
Autoimmune markers
-
Iron studies, ceruloplasmin
-
Alpha-1 antitrypsin levels
-
-
Imaging:
-
Ultrasound
-
CT or MRI
-
FibroScan (liver stiffness measurement)
-
-
Liver biopsy:
-
Gold standard for assessing inflammation and fibrosis
-
Treatment
Management focuses on treating the underlying cause and preventing progression:
-
Viral hepatitis: Antiviral therapy (often curative for hepatitis C)
-
NAFLD: Weight loss (7–10%), metabolic optimization
-
Alcohol-related disease: Complete abstinence
-
Autoimmune disease: Immunosuppressive therapy
-
Genetic conditions: Targeted treatments (e.g., iron or copper reduction)
Supportive care includes:
-
Avoiding alcohol and hepatotoxic substances
-
Maintaining proper nutrition
-
Managing complications (ascites, encephalopathy, varices)
-
Vaccination against hepatitis A and B
Monitoring & Complications
-
Regular blood tests and imaging
-
Screening for liver cancer (hepatocellular carcinoma)
-
Endoscopy for esophageal varices
Prognosis
Outcomes depend on the cause and stage at diagnosis:
-
Early-stage disease may stabilize or improve
-
Cirrhosis is often irreversible but manageable
-
Decompensated cirrhosis has a poor prognosis without intervention
Liver transplantation is the definitive treatment for advanced disease, with 5-year survival rates exceeding 75% in many cases.
Prevention
-
Limit alcohol intake
-
Maintain a healthy weight
-
Manage diabetes and cholesterol
-
Get vaccinated for hepatitis A and B
-
Practice safe behaviors to prevent viral hepatitis
-
Use medications responsibly
-
Seek early medical evaluation for risk factors
Show more